Security key
N69605108
Pharvaris N.V. - Ordinary Shares, par value Euro 0.12 per share (PHVS)
CUSIP: N69605108
Q2 2023 13F Holders as of 30 Jun 2023
- Security type / class
- Equity / Ordinary Shares, par value Euro 0.12 per share
- Total 13F shares
- 28,913,752
- Total 13F value
- $441,577,880
- Share change
- +7,132,258
- SEC-reported price per share
- $15.14
- Number of holders
- 21
- Value change
- +$109,619,000
- Number of buys
- 11
- Number of sells
- 6
- Shares outstanding
- 69,889,980
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2023
Institutions
21
Top holders
10
PHVS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Pharvaris N.V. SEC filings
Pharvaris N.V. company facts
Broader feeds
Reporting periods
Holder history for CUSIP N69605108
Recent filing periods:
Ownership snapshot
Top reported holders of PHVS - Pharvaris N.V. - Ordinary Shares, par value Euro 0.12 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
Foresite Capital Manageme...
Comparable rows
15/15
Latest evidence
31 Mar 2023
13F
Lead comparable stake: 4.7%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 4.7%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
4.7%
Foresite Capital Management IV, LLC
4.6%
VIKING GLOBAL INVESTORS LP
4.6%
Bain Capital Life Sciences Invest...
4.6%
GENERAL ATLANTIC, L.P.
3.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
4.7%
|
$25,925,161
3,315,238 shares
|
— | 31 Mar 2023 |
| Foresite Capital Management IV, LLC |
13F
Company
|
4.6%
|
$26,153,989
3,246,926 shares
|
— | 31 Mar 2023 |
| VIKING GLOBAL INVESTORS LP |
13F
Company
|
4.6%
|
$25,273,638
3,231,923 shares
|
— | 31 Mar 2023 |
| Bain Capital Life Sciences Investors, LLC |
13F
Company
|
4.6%
|
$25,620,000
3,180,601 shares
|
— | 31 Mar 2023 |
| GENERAL ATLANTIC, L.P. |
13F
Company
|
3.5%
|
$19,494,349
2,420,155 shares
|
— | 31 Mar 2023 |
| venBio Partners LLC |
13F
Company
|
3.3%
|
$18,353,922
2,278,575 shares
|
— | 31 Mar 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
21
Shares
28,913,752
Rows available
21
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q3 2025 Across Filers
Q3 2025 holders
83
Q2 2023 holders
21
Holder diff
-62
| Investor | Q3 2025 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q3 2025 value | Q2 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend